Full range of solutions

Pharmaprocess forum offered you a full range of learning opportunities to help you to enhace your business.In-depth sessions and specialist topics with the main experts of the pharmaceutical industry.

Check out the programme

	27 OCTOBER
	REGULATORY & DEVELOPMENT Management strategy to reduce time to market	OPERATIONS Factories for the future	GOOD DISTRIBUTION PRACTICES Regulatory impact from procurement to the client	BUSINESS DEVELOPEMENT Future and current business
09:30-10:00	RECEPTION
10:00 - 10:30	Introduction: Mr. Ton Capella - PHARMAprocess President OPENING: EPIGENETICS IN HEALTH AND DISEASE: FROM KNOWLEDGE TO APPLICATIONS Dr. Manel Esteller, Director of the Cancer Epigenetics and Biology Program (PEBC) - Bellvitge Institute for Biomedical Research (IDIBELL) Moderator: Mr. Santiago Alsina - PHARMAproces Scientific Committee Coordinator
10:30-11:30	PLENARY: THE FIGHTING IN SPAIN AGAINST COUNTERFEITING: THE DIRECTIVE AND THE DELEGATE ACT Ms. Belén Escribano Romero, Head of the Department of Inspection and Control Medicines - Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) \| Ms. Sonia Ruíz Morán, President EMVO Moderator: Sra. Iciar Sanz de Madrid, Director of International Affairs Farmaindustria
11:30-12:00	COFEE BREAK AND VISIT THE EXHIBITION AREA - LEVEL 0
12:00-13:00	DATA INTEGRITY, A NOVARTIS APPROACH Mr. James Mann Head Data Integrity Program Management - Novartis Pharma AG / Ms. Anna Coso, SQA-AS&T Manager Alcon, a Novartis Company /Moderator: Mr. Georg Roessling, Senior Vice President - PDA Europe	BARRIER TECHNOLOGY (ISOLATOR AND RABS) TRENDS AND ITS MANAGEMENT Mr. Jack Lysfjord, Principal Consultant - Lysfjord Consulting LLC / Moderator: Dr. Carles Cirera, Vice Chair - ISPE	INDUSTRY SESSION MAXIMIZING EFFICIENCY: PROCESS ANALYTICAL AND PROCESS INTENSIFICATION Mr. Alejandro Rosales, Scientific and Technological Manager - IRIS / Moderator: Mr. Enric Jo, Site Director - Reig Jofre Group	NUTRACEUTICALS ARE PART OF THE FUTURE?. NYADITUM RESAE® A SUCCESFUL CASE Mr. Pere Joan Cardona, CEO / CSO - Manremyc / Moderator: Ms. Mercedes Rodríguez Barrera, Corporate Development & Strategic Planning Director - JUSTE S.A.Q.F
13:00-14:00	ANEX 15 AND NEW FDA/EMA VALIDATION GUIDE Ms. Rosa María González del Egido, Process Quality Department - Quality Area - Boehringer Ingleheim / Mr. Xavier Casterat, Technical Inspector - Generalitat de Catalunya - Health Department / Moderator: Mrs Beatriz Artalejo, President - AEFI	GROUNDBREAKING PCMM CONCEPT Mr. Michael O'Brien, Vice President - Pfizer Inc. / Moderator: Mr. Xavier Farrés Torrecabota, Operations Director - Uriach	GDP. WHAT IS THE IMPACT TO THE API MANUFACTURERS? Ms. Cristina Fernández Soligo, Quality Auditor - Laboratorios Dr. Esteve / Mr. Bertil Wagensveld, Global Logistics Director - TEVA API Division / Moderator: Dr. Georgina Pujals i Naranjo, GMP Inspector - Pharmaceutical and Medical Devices Control - Generalitat de Catalunya - Health Department	INDUSTRY SESSION "E-BEAM STERILIZATION SYSTEM APPLIED FOR AN ISOLATOR"&NBSP;LAST NEWS. Mr. Koji Kawasaki, President - Airex Co. Ltd / Moderator: Mr. Rafael Beaus, Area Sales Manager - Telstar
14:00-15:30	NETWORKING LUNCH - LEVEL 0 (Only for delegates)
15:30-16:30	INDUSTRY SESSION EU GMP CHANGE-IMPACT ON CLEANING AND PROCESS VALIDATION Mr. Walid El Azab, Technical Service Manager - STERIS Life Sciences / Moderator: Mr. Rafael Beaus, Area Sales Manager - Telstar	THE CHEMICAL AND PHARMACEUTICAL PROCESSES FROM THE BIG DATA POINT OF VIEW: A TRULY INNOVATION Mr. Toni Manzano, CSO - Bigfinite / Moderator: Mr. Juan Nuñez García, Operational Excellence Responsible - Almirall	GDP. WHAT IS THE IMPACT TO THE DISTRIBUTORS? Mr. Hanness Laessig, Global Product Manager Pharma Sea Logistics - Kuehne + Nagel (AG & Co.) KG / Mr. Marc Meseguer, European Developer Reefer - Kuene + Nagel / Mr. Marco Antonio Peralta, Iberia QA Manager - DHL Exel Supply Chain SLU / Moderator: Mr. Jaime Mira, Technical Director - ICIL Foundation	DEAL TRENDS: BD AND PRODUCTION IMPACTS Ms. Sharon Finch, CEO - Medius Associates / Moderator: Mr. Enric Turmó, Senior Licensing Manager Business Development - Laboratorios ESTEVE
16:30-17:30	MEDICAL DEVICE INNOVATION Ms. Ioana Riaño Fernández, Unit Responsible for clinical research and clinical trials - Biodonostia Health Research Institute - Donostia University Hospital / Mr. Carlos Sisternas, Director - FENIN Moderator: Ms. Mª Angeles Bravo, Technical Director - Proclinic	INDUSTRY SESSION CONTINUOUS MANUFACTURING CONCEPTS (CONSIGMATM) OPTIMIZING YOUR OPERATIONS. Mr. Wim van der Goten, Sales Director - GEA Pharma / Moderator: Ms. Clara Campás - KERN Pharma	GDP. WHAT IS THE IMPACT TO THE FDF MANUFACTURERS? Ms. Iosune Galar Iribarren, Quality Assurance - Laboratorios CINFA / Mr. Carlos Clemente, General Manager - Disalfarm SA / Mr. Joan Sansalvador, Partner - Labware SA, Azbil Telstar Group / Moderator: Mr. Salvador Cassany, Head of Pharmaceutical and Medical Devices Control Unit - Ministry of Health - Generalitat de Catalunya	CHANNELING NICHE PHARMA PRODUCTS TO EUROPEAN MARKET Ms. Nina Fleck, Senior Director Corporate - Development LLM - Sobi / Moderator: Ms. Emma Gasol, Business Development Director, In-Licensing - Gebro Pharma
17:45	PHARMA Experience – TECHNICAL GUIDED VISIT AT ALMIRALL PHARMA PLANT
18:00	PHARMA Experience – TECHNICAL VISIT AT BARCELONA BIOMEDICAL RESEARCH PARK (PRBB)

	28 OCTOBER
	REGULATORY & DEVELOPMENT Management strategy to reduce time to market	OPERATIONS Factories for the future	GOOD DISTRIBUTION PRACTICES Regulatory impact from procurement to the client	BUSINESS DEVELOPEMENT Future and current business
9:30-10:30	PLENARY: ADVANCED METHODS FOR OPERATIONAL EXCELLENCE Dr. Hirozuki Sugiyama, Associate Professor - The University of Tokyo - Board Member of ISPE Japan / Mr. Ángel Albizu Mardones, Senior Leader Consultant - ASENTA Management Consultants Moderator: Mr. Xavier Farrés Torrecabota, Operations Director - Uriach
10:45-11:45	MARKET ACCES INTEGRATION IN QBD STRATEGY Ms. Mercedes Prior, Head of Global Market Access - Global Medical Affairs & Market Access - Almirall / Moderator: Mr. Carlos Maestro, Board of Director Member - ISPE Spain Affiliate	COST COMPARISON BETWEEN EU/USA AND EMERGING PLANTS. OPEX BENCHMARKING Mr. Nicolás Ponce, Research Associate Institute of Technology Management, University of St. Gallen / Moderator: Dr. Carles Cirera, Vice Chair - ISPE	CEIV PHARMA PROJECT Mr. Francisco Rizzuto, Cargo Manager for Western Europe - IATA - International Air Transport Association / Mr. Jaume Adrover Rigo, General Director - Gestió i Promoció Aeroportuària (GPA) / Moderator: Dr. Carmen Martínez, Senior Advisor - GRF & Partners	INDUSTRY SESSION HIGH SOPHISTICATED TECHNOLOGIES FOR OSD: HOTMELT GRANULATION AND COATING Mr. Thomas B. Kordik, Area Sales Manager - Romaco Innojet GmbH / Dr. Detlev Haak, Director R&D - Hermes Arzneimittel GmbH, Division HERMES Pharma / Moderator: Mr. Santiago Alsina, Scientific Coordinator - PHARMAprocess
11:45-12:15	COFFEE BREAK AND VISIT EXHIBITION AREA - LEVEL 0
12:30-13:30	QbD AT MINIMUM OR "FULL APPLICATION" Ms. Alicia Tébar, Director - QbD Pharmaceutical Services / Mr. Frédéric Vaurès, Technical Manager - Colorcon Ibérica / Moderator: Ms. Beatriz Artalejo, President - AEFI	INDUSTRY SESSION SAVE COST WITH PROPORTIONAL VALVE TECHNOLOGY FOR INERT GASES Mr. Thomas Schulz, Head of Industry segment & Key Account management Biotech/Pharma/Cosmetics - Festo AG & Co. KG / Moderator: Mr. Juan Núñez García, Operationa Excellence Responsible - Almirall	CIRCULAR ECONOMY AND ECOLOGICAL INTELLIGENCE: LIFE CYCLE AND CARBON FOOTPRINT WITHIN THE PHARMA SECTOR Dr. Pere Fullana i Palmer, UNESCO Chair in Life Cycle and Climate Change - ESCI-UPF / Moderator: Ms. Elvira Carles, Directora - Fundació Empresa i Clima	HOW TO BE AN EFFICIENT DIGITAL PLANT Mr. Rocco Lisi - Accenture / Moderator: Mr. Carlos Maestro, Board of Director Member - ISPE Spain Affiliate
13:30-15:00	NETWORKING LUNCH - LEVEL 0 (Only for delegates)
15:00-16:00	NANO-DRUG DELIVERY Ms. Mª José Alonso, Professor - University of Santiago de Compostela / Prof. Dr. Víctor F. Puntes, Professor VHIR / Moderator: Ms. Beatriz Artalejo, President - AEFI	INDUSTRY SESSION CONTINOUS LYOPHILLIZATION Mr. Robert Bullich, Process Laboratory Manager - Azbil Tesltar Technologies / Moderator: Dr. Enric Jo, Site Director - Reig Jofre Group	SUPPLY SHORTAGE IN A GLOBAL CONTEXT Ms. Alison Dawson, QA Leader - EU Ext. Advocacy & Collabns - Lilly / Moderator: Mr. Salvador Cassany, Head of Pharmaceutical and Medical Devides Control Unit - Ministry of Health - Generalitat de Catalunya	MARKET ACCESS CONSIDERATIONS IN ASSET VALUATION Ms. Monique Martin, Vice President and General Manager - Mapi / Moderator: Ms. Rosa-Marta Domènech Montagut,Commercial Excellence Head- Novartis Farmacéutica, S.A.
16:15-17:15	PLENARY: DIGITAL MANUFACTAURING IN PHARMA INDUSTRY Mr. Ben Salama, Managing Director - Accenture / Mr. Jordi Ibañez, Managing Director lead for Life Sciences - Accenture / Moderator: Mr. Joan Navales, Operations Director - Laboratorios Dr. Esteve
17:25-19:00